1. Home
  2. FTRE vs ARQQ Comparison

FTRE vs ARQQ Comparison

Compare FTRE & ARQQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTRE
  • ARQQ
  • Stock Information
  • Founded
  • FTRE 1996
  • ARQQ 2017
  • Country
  • FTRE United States
  • ARQQ United Kingdom
  • Employees
  • FTRE N/A
  • ARQQ N/A
  • Industry
  • FTRE Medical Specialities
  • ARQQ Computer Software: Prepackaged Software
  • Sector
  • FTRE Health Care
  • ARQQ Technology
  • Exchange
  • FTRE Nasdaq
  • ARQQ Nasdaq
  • Market Cap
  • FTRE 468.1M
  • ARQQ 531.6M
  • IPO Year
  • FTRE N/A
  • ARQQ N/A
  • Fundamental
  • Price
  • FTRE $6.80
  • ARQQ $38.33
  • Analyst Decision
  • FTRE Hold
  • ARQQ Strong Buy
  • Analyst Count
  • FTRE 11
  • ARQQ 1
  • Target Price
  • FTRE $16.00
  • ARQQ $52.00
  • AVG Volume (30 Days)
  • FTRE 2.5M
  • ARQQ 940.1K
  • Earning Date
  • FTRE 08-06-2025
  • ARQQ 05-22-2025
  • Dividend Yield
  • FTRE N/A
  • ARQQ N/A
  • EPS Growth
  • FTRE N/A
  • ARQQ N/A
  • EPS
  • FTRE N/A
  • ARQQ 0.48
  • Revenue
  • FTRE $2,685,600,000.00
  • ARQQ $241,000.00
  • Revenue This Year
  • FTRE N/A
  • ARQQ $284.30
  • Revenue Next Year
  • FTRE $0.93
  • ARQQ $415.45
  • P/E Ratio
  • FTRE N/A
  • ARQQ $79.13
  • Revenue Growth
  • FTRE N/A
  • ARQQ N/A
  • 52 Week Low
  • FTRE $3.97
  • ARQQ $3.72
  • 52 Week High
  • FTRE $27.99
  • ARQQ $52.79
  • Technical
  • Relative Strength Index (RSI)
  • FTRE 69.65
  • ARQQ 53.37
  • Support Level
  • FTRE $4.46
  • ARQQ $37.20
  • Resistance Level
  • FTRE $6.85
  • ARQQ $41.50
  • Average True Range (ATR)
  • FTRE 0.47
  • ARQQ 3.84
  • MACD
  • FTRE 0.21
  • ARQQ -0.53
  • Stochastic Oscillator
  • FTRE 97.96
  • ARQQ 24.39

About FTRE Fortrea Holdings Inc.

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

About ARQQ Arqit Quantum Inc.

Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.

Share on Social Networks: